MR CLEAN is a Dutch trial that investigated treatment of a severe form of ischaemic stroke (blockage type stroke) with thrombolysis alone (dissolving a clot with clot-busting drugs), versus treatment with both thrombolysis.
Although speech and language therapists (SLTs) may help aphasia patients with their rehabilitation, there remains a clear lack of evidence-based treatments available for them to help their patients with problems of everyday talking, known as ‘discourse’. This study aims to address both the need for evidence-based treatments and improvement of clinical expertise to address discourse problems af
Presented at the International Stroke Conference 2016, the final results from the PISTE trial (Pragmatic Ischaemic Stroke Thrombectomy Evaluation) add new evidence for the effectiveness of mechanical clot retri
This study will investigate how other illnesses can affect stroke treatment and outcome. It will involve the analysis of electronic, linked datasets of health information from stroke patients in Scotland.
On 12 February 2015, at the International Stroke Conference (ISC 2015) in Nashville, USA, the findings of a Stroke Association funded study were presented, called CADISS (Cervical Artery Dissection In Stroke Study.
About 80% strokes are caused by a blocked blood vessel. One third of these patients have a blockage of a large blood vessel in the neck or brain known as large artery occlusion stroke (LAOS).
CADASIL is one of the most common genetic causes of stroke and dementia. Currently there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.
An ischaemic stroke happens when a blood clot, or other blockage, cuts off the blood supply to your brain. This is the most common type of stroke.